About Biose Industrie
Biose Industrie is a company based in Clermont-ferrand (France) founded in 2013 was acquired by L-GAM in February 2023. It operates as a Professional Services. Biose Industrie has raised $34.25 million across 2 funding rounds from investors including Bpifrance, Cathay Capital and L-GAM. Biose Industrie offers products and services including Microbiome Therapeutics and Next Generation Probiotics. Biose Industrie operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Clermont-ferrand, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biose Industrie
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biose Industrie
Biose Industrie offers a comprehensive portfolio of products and services, including Microbiome Therapeutics and Next Generation Probiotics.
Microbiome therapeutics are developed for innovative drug solutions.
Next generation probiotics are produced for health benefits.
Funding Insights of Biose Industrie
Biose Industrie has successfully raised a total of $34.25M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $34.25 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biose Industrie
Biose Industrie has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Cathay Capital and L-GAM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cathay Capital is engaged in global investment and transformation.
|
Locked | Locked | Locked | |
|
L-GAM is engaged in mid-market investments across Europe.
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for Biose Industrie
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biose Industrie
Investment portfolio details for Biose Industrie
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biose Industrie
Detailed financials for Biose Industrie
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biose Industrie Comparisons
Peer comparison for Biose Industrie
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biose Industrie
Biose Industrie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Developer of therapeutics for microbiome based diseases
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
Detailed competitors of Biose Industrie
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biose Industrie
Complete news archive for Biose Industrie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biose Industrie
Biose Industrie was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Biose Industrie is headquartered in Clermont-ferrand, France. It is registered at Clermont-ferrand, Auvergne-rhone-alpes, France.
Biose Industrie is a funded company, having raised a total of $34.25M across 2 funding rounds to date.
Biose Industrie is established as a global Contract Development and Manufacturing Organization (CDMO) specializing in microbiome therapeutics and next generation probiotics. The company is focused on bioproduction, integrating analytical and industrial expertise to support clients from project development to commercial launch. Services are provided in the healthcare and biotechnology sectors, addressing innovative drug categories using microorganisms. Facilities are maintained in France and the USA to cater to international markets. Regulatory requirements and market needs are anticipated to ensure client satisfaction and project success.
Biose Industrie's top competitors include KBI Biopharma, Aldevron and Ovagen.
Biose Industrie offers Microbiome Therapeutics and Next Generation Probiotics.
Biose Industrie has 3 investors. Key investors include Bpifrance, Cathay Capital, and L-GAM.